Table of Content

1 Market Overview of Antiretroviral Drug
1.1 Antiretroviral Drug Market Overview
1.1.1 Antiretroviral Drug Product Scope
1.1.2 Antiretroviral Drug Market Status and Outlook
1.2 Global Antiretroviral Drug Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Antiretroviral Drug Market Size by Region (2018-2034)
1.4 Global Antiretroviral Drug Historic Market Size by Region (2018-2024)
1.5 Global Antiretroviral Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Antiretroviral Drug Market Size (2018-2034)
1.6.1 North America Antiretroviral Drug Market Size (2018-2034)
1.6.2 Europe Antiretroviral Drug Market Size (2018-2034)
1.6.3 Asia-Pacific Antiretroviral Drug Market Size (2018-2034)
1.6.4 Latin America Antiretroviral Drug Market Size (2018-2034)
1.6.5 Middle East & Africa Antiretroviral Drug Market Size (2018-2034)
2 Antiretroviral Drug Market by Type
2.1 Introduction
2.1.1 Multi-Class Drugs Combination
2.1.2 NRTI
2.1.3 NNRTI
2.1.4 Protease Inhibitors
2.1.5 Other
2.2 Global Antiretroviral Drug Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Antiretroviral Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Antiretroviral Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Antiretroviral Drug Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Antiretroviral Drug Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Antiretroviral Drug Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Antiretroviral Drug Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Antiretroviral Drug Revenue Breakdown by Type (2018-2034)
3 Antiretroviral Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Pharmaceutical Companies
3.1.3 Other
3.2 Global Antiretroviral Drug Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Antiretroviral Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Antiretroviral Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Antiretroviral Drug Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Antiretroviral Drug Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Antiretroviral Drug Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Antiretroviral Drug Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Antiretroviral Drug Revenue Breakdown by Application (2018-2034)
4 Antiretroviral Drug Competition Analysis by Players
4.1 Global Antiretroviral Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2022)
4.3 Date of Key Players Enter into Antiretroviral Drug Market
4.4 Global Top Players Antiretroviral Drug Headquarters and Area Served
4.5 Key Players Antiretroviral Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Antiretroviral Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Gilead Sciences
5.1.1 Gilead Sciences Profile
5.1.2 Gilead Sciences Main Business
5.1.3 Gilead Sciences Antiretroviral Drug Products, Services and Solutions
5.1.4 Gilead Sciences Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Gilead Sciences Recent Developments
5.2 ViiV Healthcare
5.2.1 ViiV Healthcare Profile
5.2.2 ViiV Healthcare Main Business
5.2.3 ViiV Healthcare Antiretroviral Drug Products, Services and Solutions
5.2.4 ViiV Healthcare Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.2.5 ViiV Healthcare Recent Developments
5.3 Bristol-Myer Squibb
5.3.1 Bristol-Myer Squibb Profile
5.3.2 Bristol-Myer Squibb Main Business
5.3.3 Bristol-Myer Squibb Antiretroviral Drug Products, Services and Solutions
5.3.4 Bristol-Myer Squibb Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.3.5 AbbVie Recent Developments
5.4 AbbVie
5.4.1 AbbVie Profile
5.4.2 AbbVie Main Business
5.4.3 AbbVie Antiretroviral Drug Products, Services and Solutions
5.4.4 AbbVie Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.4.5 AbbVie Recent Developments
5.5 Boehringer-Ingelheim
5.5.1 Boehringer-Ingelheim Profile
5.5.2 Boehringer-Ingelheim Main Business
5.5.3 Boehringer-Ingelheim Antiretroviral Drug Products, Services and Solutions
5.5.4 Boehringer-Ingelheim Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Boehringer-Ingelheim Recent Developments
5.6 Johnson and Johnson
5.6.1 Johnson and Johnson Profile
5.6.2 Johnson and Johnson Main Business
5.6.3 Johnson and Johnson Antiretroviral Drug Products, Services and Solutions
5.6.4 Johnson and Johnson Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Johnson and Johnson Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Antiretroviral Drug Products, Services and Solutions
5.7.4 Merck Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Merck Recent Developments
5.8 CIPLA
5.8.1 CIPLA Profile
5.8.2 CIPLA Main Business
5.8.3 CIPLA Antiretroviral Drug Products, Services and Solutions
5.8.4 CIPLA Antiretroviral Drug Revenue (US$ Million) & (2018-2024)
5.8.5 CIPLA Recent Developments
6 North America
6.1 North America Antiretroviral Drug Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Antiretroviral Drug Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antiretroviral Drug Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antiretroviral Drug Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antiretroviral Drug Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antiretroviral Drug Market Dynamics
11.1 Antiretroviral Drug Industry Trends
11.2 Antiretroviral Drug Market Drivers
11.3 Antiretroviral Drug Market Challenges
11.4 Antiretroviral Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antiretroviral Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Antiretroviral Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Antiretroviral Drug Market Size Share by Region (2018-2024)
Table 4. Global Antiretroviral Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Antiretroviral Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Antiretroviral Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Antiretroviral Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Antiretroviral Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Antiretroviral Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Antiretroviral Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Antiretroviral Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Antiretroviral Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Antiretroviral Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Antiretroviral Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Antiretroviral Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Antiretroviral Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Antiretroviral Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Antiretroviral Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Antiretroviral Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Antiretroviral Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Antiretroviral Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Antiretroviral Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Antiretroviral Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Antiretroviral Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Antiretroviral Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Antiretroviral Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Antiretroviral Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Antiretroviral Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Antiretroviral Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Antiretroviral Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Antiretroviral Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Antiretroviral Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Antiretroviral Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Antiretroviral Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Antiretroviral Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Antiretroviral Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Antiretroviral Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2022)
Table 39. Date of Key Players Enter into Antiretroviral Drug Market
Table 40. Global Antiretroviral Drug Key Players Headquarters and Area Served
Table 41. Antiretroviral Drug Product Solution and Service
Table 42. Global Antiretroviral Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Gilead Sciences Basic Information List
Table 45. Gilead Sciences Description and Business Overview
Table 46. Gilead Sciences Antiretroviral Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antiretroviral Drug Business of Gilead Sciences (2018-2024)
Table 48. Gilead Sciences Recent Developments
Table 49. ViiV Healthcare Basic Information List
Table 50. ViiV Healthcare Description and Business Overview
Table 51. ViiV Healthcare Antiretroviral Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antiretroviral Drug Business of ViiV Healthcare (2018-2024)
Table 53. ViiV Healthcare Recent Developments
Table 54. Bristol-Myer Squibb Basic Information List
Table 55. Bristol-Myer Squibb Description and Business Overview
Table 56. Bristol-Myer Squibb Antiretroviral Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antiretroviral Drug Business of Bristol-Myer Squibb (2018-2024)
Table 58. Bristol-Myer Squibb Recent Developments
Table 59. AbbVie Basic Information List
Table 60. AbbVie Description and Business Overview
Table 61. AbbVie Antiretroviral Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Antiretroviral Drug Business of AbbVie (2018-2024)
Table 63. AbbVie Recent Developments
Table 64. Boehringer-Ingelheim Basic Information List
Table 65. Boehringer-Ingelheim Description and Business Overview
Table 66. Boehringer-Ingelheim Antiretroviral Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Antiretroviral Drug Business of Boehringer-Ingelheim (2018-2024)
Table 68. Boehringer-Ingelheim Recent Developments
Table 69. Johnson and Johnson Basic Information List
Table 70. Johnson and Johnson Description and Business Overview
Table 71. Johnson and Johnson Antiretroviral Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Antiretroviral Drug Business of Johnson and Johnson (2018-2024)
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck Basic Information List
Table 75. Merck Description and Business Overview
Table 76. Merck Antiretroviral Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Antiretroviral Drug Business of Merck (2018-2024)
Table 78. Merck Recent Developments
Table 79. CIPLA Basic Information List
Table 80. CIPLA Description and Business Overview
Table 81. CIPLA Antiretroviral Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Antiretroviral Drug Business of CIPLA (2018-2024)
Table 83. CIPLA Recent Developments
Table 84. North America Antiretroviral Drug Market Size by Country (2018-2024) & (US$ Million)
Table 85. North America Antiretroviral Drug Market Size by Country (2024-2034) & (US$ Million)
Table 86. Europe Antiretroviral Drug Market Size by Country (2018-2024) & (US$ Million)
Table 87. Europe Antiretroviral Drug Market Size by Country (2024-2034) & (US$ Million)
Table 88. Asia-Pacific Antiretroviral Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 89. Asia-Pacific Antiretroviral Drug Market Size by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Antiretroviral Drug Market Size by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Antiretroviral Drug Market Share by Region (2018-2024)
Table 92. Asia-Pacific Antiretroviral Drug Market Share by Region (2024-2034)
Table 93. Latin America Antiretroviral Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 94. Latin America Antiretroviral Drug Market Size by Country (2018-2024) & (US$ Million)
Table 95. Latin America Antiretroviral Drug Market Size by Country (2024-2034) & (US$ Million)
Table 96. Middle East & Africa Antiretroviral Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 97. Middle East & Africa Antiretroviral Drug Market Size by Country (2018-2024) & (US$ Million)
Table 98. Middle East & Africa Antiretroviral Drug Market Size by Country (2024-2034) & (US$ Million)
Table 99. Antiretroviral Drug Market Trends
Table 100. Antiretroviral Drug Market Drivers
Table 101. Antiretroviral Drug Market Challenges
Table 102. Antiretroviral Drug Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiretroviral Drug Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Antiretroviral Drug Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Antiretroviral Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Antiretroviral Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Antiretroviral Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Antiretroviral Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Antiretroviral Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Antiretroviral Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Antiretroviral Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Multi-Class Drugs Combination
Figure 11. Global Multi-Class Drugs Combination Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of NRTI
Figure 13. Global NRTI Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of NNRTI
Figure 15. Global NNRTI Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Protease Inhibitors
Figure 17. Global Protease Inhibitors Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of Other
Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Global Antiretroviral Drug Market Size Share by Type: 2022 & 2034
Figure 21. North America Antiretroviral Drug Revenue Market Share by Type (2018-2034)
Figure 22. Europe Antiretroviral Drug Revenue Market Share by Type (2018-2034)
Figure 23. Asia-Pacific Antiretroviral Drug Revenue Market Share by Type (2018-2034)
Figure 24. Latin America Antiretroviral Drug Revenue Market Share by Type (2018-2034)
Figure 25. Middle East and Africa Antiretroviral Drug Revenue Market Share by Type (2018-2034)
Figure 26. Hospital Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Pharmaceutical Companies Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 28. Other Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Global Antiretroviral Drug Market Size Share by Application: 2022 & 2034
Figure 30. North America Antiretroviral Drug Revenue Market Share by Application (2018-2034)
Figure 31. Europe Antiretroviral Drug Revenue Market Share by Application (2018-2034)
Figure 32. Asia-Pacific Antiretroviral Drug Revenue Market Share by Application (2018-2034)
Figure 33. Latin America Antiretroviral Drug Revenue Market Share by Application (2018-2034)
Figure 34. Middle East and Africa Antiretroviral Drug Revenue Market Share by Application (2018-2034)
Figure 35. Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Antiretroviral Drug Market Share in 2022
Figure 37. North America Antiretroviral Drug Market Share by Country (2018-2034)
Figure 38. U.S. Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 39. Canada Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 40. Germany Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 41. France Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 42. U.K. Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 43. Italy Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 44. Russia Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 45. Nordic Countries Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 46. Asia-Pacific Antiretroviral Drug Market Share by Region (2018-2034)
Figure 47. China Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 48. Japan Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 49. South Korea Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 50. Southeast Asia Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 51. India Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 52. Australia Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 53. Latin America Antiretroviral Drug Market Share by Country (2018-2034)
Figure 54. Mexico Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 55. Brazil Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 56. Middle East & Africa Antiretroviral Drug Market Share by Country (2018-2034)
Figure 57. Turkey Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 58. Saudi Arabia Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 59. UAE Antiretroviral Drug Market Size (2018-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report